Hyperfractionated accelerated radiochemotherapy (HFA-RCT) with mitomycin C for advanced head and neck cancer.

[1]  P. Wust,et al.  Accelerated hyperfractionated radiation therapy to 70.6 Gy plus 5-FU/MMC (C-HART) is more effective than HART to 77.6 Gy alone for locally advanced head and neck cancer. Four-year results of the German ARO 95-6 trial in 384 patients , 2003 .

[2]  L. Bastholt,et al.  Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer , 2003 .

[3]  Cai Grau,et al.  Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial , 2003, The Lancet.

[4]  C. Grau,et al.  Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  D. Sidransky,et al.  Head and neck cancer. , 2001, The New England journal of medicine.

[6]  J. Naude,et al.  Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  J. Bourhis,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.

[8]  M. Parmar,et al.  Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptoms , 1999, British Journal of Cancer.

[9]  W. Millesi,et al.  Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer. , 1998, International journal of radiation oncology, biology, physics.

[10]  R. Spiro,et al.  A prospective phase ii trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck , 1998, Head & neck.

[11]  Jay S. Cooper,et al.  A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 , 1999 .

[12]  S. Rockwell,et al.  Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Rockwell,et al.  Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. , 1993, International journal of radiation oncology, biology, physics.